Feasibility Study on the FARAVIEW Technology

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 3, 2024

Primary Completion Date

May 15, 2025

Study Completion Date

June 6, 2025

Conditions
Atrial FibrillationParoxysmal Atrial FibrillationPersistent Atrial Fibrillation
Interventions
DEVICE

Ablation Treatment

For subjects with paroxysmal AF, Pulmonary Vein Isolation will be performed with the FARAWAVE NAV catheter. For subjects with persistent AF, left atrial posterior wall isolation (PWI) may also be performed at the discretion of the investigator, with the FARAWAVE NAV PFA catheter.

Trial Locations (3)

15030

Na Homolce Hospital, Prague

31008

Clínica Universidad de Navarra, Pamplona

7 D07 RD8P

Mater Private Hospital, Dublin

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY